This informative two day conference will give delegates the opportunity to hear the latest advancements in Big Data focusing on analytics for upstream exploration and production. Attendees will hear from a variety of industry expertise including operator case studies and leading big data vendors. In the last two years alone, Hadoop hit the big time, in-memory arrived, and practitioners saw data analysis deliver real results. This vast jump in...

Join SMi's Simulating Clinical Trials Using the FACTS Software Package event on the 9 July in London, to hear how simulation of clinical trials is used in the trial design process and how it benefits. Medical simulation is no longer an educational afterthought – it's a clinical learning necessity. Simulation adds considerable advantages to the clinical trial design process – using previous research data to its full potential, clari...

Over the next six years, the global mHealth market will continue to make a mark in a serious way, with the industry poised to exceed $49.1 billion by 2020, according to a new market report. According to research conducted by San Francisco-based market analysis and Grand View Research, monitoring services are projected to remain the dominant and most rapidly growing market segment, with revenue topping $1.2 billion in 2012, and seeing a nearly...

Join SMi's IP and the Generics Industry masterclass taking place on the 8 July in London, to navigate through the complicated landscape of intellectual property and generics.Intellectual Property (IP) lies at the very heart of the generics industry and it is vital to understand why the subject is so important. It represents the front line in the battles between originators , who want to protect their inventions for as long as possible, and the...

Since the European Paediatric Regulation was introduced in 2007, companies developing new medicinal products or new indications/routes of administration/pharmaceutical forms are obliged to present age-appropriate formulations for the paediatric population within a Paediatric Investigation Plan (PIP) to the European Medicines Agency. Paediatric drug development has become an essential part of drug development in general, it is a very complex ar...

What can we learn from the 4 floating LNG liquefaction units sanctioned to date? Hosted by ThyssenKrupp Uhde Energy and Power Visiongain values the global Floating LNG (FLNG) market at $11.845bn in 2014, with market forecasts predicting strong expansion over the next five years, reaching peak levels of CAPEX in 2018. With 4 FLNG projects now in the EPC phase some 'golden threads' are starting to appear - both technically and commercially. SMi'...

With one-third of the global population online, recent studies show that about 79% of all telecommunication customers are now relying on social media networks for information regarding products and services. In other words, over half of these costumers are logging on to Facebook, Twitter, Linkedln, etc. to learn more about telecommunication providers. But what is challenging for telecom companies is figuring out how to engage such a big audien...

Fraud is a collaborative criminal issue that requires a collaborative response and so Big Data can have a significant role in enabling organisations to detect and prevent criminal activity. Delegates of this master class will be introduced to the current fraud and cybercrime landscape which is having an impact to both public and private sector organisations worldwide. Through a series of interactive discussions delegates will learn how the pro...

This important and timely meeting will allow biotech, pharma, academic and funding organisations to evaluate how they partner with other stakeholders in the field to accelerate research and reduce costs. Join us and hear timely case studies, presentations, roundtables and panel discussions on the hottest topics, from leading experts as they demonstrate how to create winning strategic partnerships from modern day collaborations! Key Topics will...

The global lyophilisation for pharmaceuticals products and services market will reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products. SMi is very pleased to present the 2nd annual Lyophilisation conference on 7-8 July 2014...